摘要
目的探讨替雷利珠单抗致Stevens-Johnson综合征不良反应的治疗方法,为临床预防及治疗提供参考。方法临床药师对1例肺腺癌患者使用化疗联合替雷利珠单抗后出现Stevens-Johnson综合征的病例进行分析和讨论,协助医师制定治疗措施。结果患者经糖皮质激素及免疫球蛋白治疗后,皮肤症状缓解。结论警示临床人员充分认识该药所导致的严重不良反应,重视和早期识别免疫相关不良反应,确保安全使用管理,提高治疗效果,为患者带来更多的临床获益。
Objective To explore the therapeutic strategies for terelizumab-induced adverse reactions to Stevens-Johnson syndrome,and to provide reference for clinical prevention and treatment of this disease.Methods Clinical pharmacists analyzed and discussed the case of Stevens-Johnson syndrome in a patient with lung adenocarcinoma treated with chemotherapy combined with tirelizumab before they assisted the physicians in formulating treatment plans.Results After corticosteroid and immunoglobulin therapy,the skin symptoms were mitigated.Conclusion Clinical pharmacists can collaborate with physicians to provide pharmacological monitoring and pharmacy services for immune-related adverse events.
作者
孙丽丹
嵇书霞
张丹
訾晨晨
王慧
鲍蕾蕾
SUN Li-dan;JI Shu-xia;ZHANG Dan;ZI Chen-chen;WANG Hui;BAO Lei-lei(Third Affiliated Hospital of Naval Military Medical University,Shanghai 200438,China;First Affiliated Hospital of Naval Military Medical University,Shanghai 200433,China;Luodian Hospital,Baoshan District,Shanghai 201908,China)
出处
《解放军药学学报》
CAS
2022年第3期252-254,共3页
Pharmaceutical Journal of Chinese People's Liberation Army